Altria Group Inc. chief executive Billy Gifford told tobacco analysts it "has become clear that two markets exist in the U.S.
Altria is the leader in tobacco with top ... based e-vapor product with marketing authorization from the U.S. Food and Drug Administration. That transaction enhanced the company's smoke-free ...
The Trump administrations removed FDA's plan to ban menthol cigarettes. The Biden administration did not finalize the rule ...
Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...
We have a leading portfolio of tobacco products for U.S. tobacco consumers age 21+. Our Vision is to responsibly lead the transition of adult smokers to a smoke-free future (Vision). We are Moving ...
10d
24/7 Wall St. on MSNIs This Dividend King Still a Buy After Disappointing Earnings?Altria (NYSE:MO) reported earnings on Thursday that beat analyst expectations, but the tobacco giant was hit with a one-two ...
Citi analysts maintained a Neutral rating on Altria Group Inc. (NYSE:MO) with a steady price target of $52.00. According to InvestingPro analysis, Altria currently trades at an attractive P/E ratio of ...
The Food and Drug Administration had in April 2022 proposed ... of dollars in annual revenue for cigarette companies such as Altria and British American Tobacco. British American Tobacco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results